The United States and India are deepening their partnership in technology, particularly in biotechnology and healthcare. This collaboration builds on a history of cooperation in areas such as disease control and public health capacities. Recent joint efforts focus on using artificial intelligence (AI) for patient treatment matching, nanotechnology for targeted...
India Gets Recognition as a Global Clinical Trials Hub
India is rapidly emerging as a premier global destination for multinational pharmaceutical companies to conduct clinical trials. This marks a significant shift in the industry landscape, driven by India's simplified, accessible, and expedited clinical trial processes. Over the past decade, India has experienced substantial growth of 15-18% in Phase 2...
Takeda Partners India’s Biological E. Limited for Dengue Vaccine
Japan's Takeda has entered into a new manufacturing partnership with Hyderabad-based Biological E. Limited (BE) in India to boost production capacity for its dengue fever vaccine Qdenga. This collaboration aims to accelerate access to Qdenga and brings Takeda closer to its goal of producing 100 million doses of the vaccine...
Takeda-BIRAC Partnership to Foster Indian Biotech Innovation
At the Global Bio-India 2023 summit, Japan-headquartered pharmaceutical company Takeda signed a three-year Memorandum of Understanding with India's Biotechnology Industry Research Assistance Council (BIRAC), a state-owned entity. Under the agreement, Takeda will provide advisory and mentoring support to Indian innovators and entrepreneurs to help them develop new healthcare solutions from...
Takeda Working with India Regulator to Bring its Dengue Vaccine
Japanese multinational pharmaceutical company, with American and British roots, Takeda, is holding talks with India’s medicine regulator, the Drug Controller General of India (DCGI), for bringing its dengue vaccine to the country. Mahender Nayak, head of Asia Pacific, Takeda Pharmaceuticals, said that the company was discussing terms of regulatory approval...




